ColiseoHead-to-Head Startup Ranking & Discovery
N
Nephrogen is a Stanford biotech spin-out developing curative genetic medicines for kidney and pancreatic diseases. Kidney disease alone affects 1 in 7 Americans, and neither indication has any approved gene-based therapies. Nephrogen's underlying platform combines AI and high-throughput screening to engineer safer, more efficient, and less expensive gene delivery vehicles for reaching the kidney and pancreas, and has attracted non-dilutive funding from seven major pharmaceutical companies including Merck KGaA, Novartis, and Bristol Myers Squibb.
Founded
2020
Headquarters
New York, NY, USA
Team size
1–10
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1472 Elo
Total matchups0
⚔️ Vote on today's matchups →Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →